Protocol № 016-P
V1.0
Updated JULY 2026
CJC-1295 with DAC protocol
A practitioner operating manual for running CJC-1295 with DAC – what to buy, how to dose and titrate, what to watch for. Mechanism: CJC-1295, a long-acting GHRH analog, was administered to normal adult subjects to identify biomarkers of GH and IGF-1 action.
At a glance
Ready to run
Route
Subcutaneous
Frequency
Weekly
Cycle
8-12 weeks
Est. cost
$60-120/month
First signal
2-4 weeks
NO AFFILIATE LINKS
Member access
The full protocol is for members only
Complete dosing guides, titration schedules, supply lists and clinical monitoring protocols are available exclusively to verified Method members.
Our membership if Free for all community members